Search results
FDA approves Labcorp companion diagnostic for Pfizer gene therapy
Medical Device Network via Yahoo Finance· 3 hours agoThe US Food and Drug Administration (FDA) has approved Labcorp’s nAbCyte Anti-AAVRh74var HB-FE assay...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 22 hours agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
Motley Fool via Yahoo Finance· 4 hours agoI owned shares of Pfizer (NYSE: PFE) when the COVID-19 pandemic started. Watching the stock soar...
5 Top Stocks to Buy in May
Motley Fool via Yahoo Finance· 2 hours agoThat's exactly how these Motley Fool contributors discuss Microsoft (NASDAQ: MSFT), Pfizer (NYSE: PFE), NextEra Energy (NYSE: NEE), Home Depot (NYSE:...
UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 5 days agoGlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies ...
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
Reuters· 16 hours agoPfizer has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired with...
Pfizer, Genmab Get Full FDA Approval for Cervical-Cancer Drug
Morningstar· 15 hours agoPfizer and Genmab on Monday said they had received full approval from U.S. regulators for their treatment for certain forms of cervical cancer. The companies' drug Tivdak ...
Pfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dose - Triangle Business...
The Business Journals· 2 days agoThe U.S. Food and Drug Administration has approved a gene therapy developed by Pfizer and...
US FDA grants full approval for Pfizer's cervical cancer drug
Reuters· 16 hours ago, opens new tab drug for treating cervical cancer patients whose disease had progressed on or after...
FDA grants full approval to cervical cancer drug TIVDAK By Investing.com
Investing.com· 14 hours agoNEW YORK & COPENHAGEN - Pfizer Inc. (NYSE: NYSE:PFE) and Genmab A/S (NASDAQ: NASDAQ:GMAB) have...
